Healthcare & Life Sciences
Akebia Therapeutics
United Statesakebia.com
Akebia Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 4 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
4
Investors
About Akebia Therapeutics
Based in the United States, Akebia Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Akebia Therapeutics is a fully integrated biopharmaceutical company developing and delivering therapies for patients with kidney disease, including two FDA-approved products that target complications of chronic kidney disease.
Explore Akebia Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.